Metraipolis › archive › dc_ff98ea4f6e44

Structure-guided screening identifies Tucatinib as dual inhibitor for MCT1/2 — Europe PMC PMID:41381736

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41381736
DOI
10.1038/s44319-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-11-07T17:22:42.870Z
SHA-256 of the archived text
e51531e3a7021131e719260a3381f51b1340bda885b1c887ddfbc36a5b8c9376
Stable URL of this page
https://metraipolis.com/documento/dc_ff98ea4f6e44

How to cite

Structure-guided screening identifies Tucatinib as dual inhibitor for MCT1/2 — Europe PMC PMID:41381736 — Europe PMC (en), https://europepmc.org/article/MED/41381736 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff98ea4f6e44 (Metraipolis archive dc_ff98ea4f6e44, sha256 e51531e3a7021131e719260a3381f51b1340bda885b1c887ddfbc36a5b8c9376)
BibTeX
@misc{dcff98ea4f6e44,
  title = {Structure-guided screening identifies Tucatinib as dual inhibitor for MCT1/2 — Europe PMC PMID:41381736},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41381736},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff98ea4f6e44; sha256 e51531e3a7021131e719260a3381f51b1340bda885b1c887ddfbc36a5b8c9376},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41381736. Agents can read the archived copy with the MCP tool read_document.